Institution
National Institute on Drug Abuse
Facility•Bethesda, Maryland, United States•
About: National Institute on Drug Abuse is a facility organization based out in Bethesda, Maryland, United States. It is known for research contribution in the topics: Dopamine & Substance abuse. The organization has 3003 authors who have published 7239 publications receiving 413116 citations. The organization is also known as: NIDA.
Topics: Dopamine, Substance abuse, Addiction, Population, Nucleus accumbens
Papers published on a yearly basis
Papers
More filters
••
TL;DR: The delineation of the neurocircuitry of the evolving stages of the addiction syndrome forms a heuristic basis for the search for the molecular, genetic, and neuropharmacological neuroadaptations that are key to vulnerability for developing and maintaining addiction.
4,160 citations
••
TL;DR: The False Discovery Rate (FDR) is the expected proportion of false discoveries among the discoveries, and controlling the FDR goes a long way towards controlling the increased error from multiplicity while losing less in the ability to discover real differences.
3,504 citations
••
TL;DR: Dopamine release in the nucleus accumbens has been linked to the efficacy of these unconditioned rewards, but dopamine release in a broader range of structures is implicated in the 'stamping-in' of memory that attaches motivational importance to otherwise neutral environmental stimuli.
Abstract: The hypothesis that dopamine is important for reward has been proposed in a number of forms, each of which has been challenged. Normally, rewarding stimuli such as food, water, lateral hypothalamic brain stimulation and several drugs of abuse become ineffective as rewards in animals given performance-sparing doses of dopamine antagonists. Dopamine release in the nucleus accumbens has been linked to the efficacy of these unconditioned rewards, but dopamine release in a broader range of structures is implicated in the 'stamping-in' of memory that attaches motivational importance to otherwise neutral environmental stimuli.
3,012 citations
••
TL;DR: Substance use disorders and mood and anxiety disorders that develop independently of intoxication and withdrawal are among the most prevalent psychiatric disorders in the United States, suggesting that treatment for a comorbid mood or anxiety disorder should be withheld from individuals with substance use disorders.
Abstract: Background Uncertainties exist about the prevalence and comorbidity of substance use disorders and independent mood and anxiety disorders. Objective To present nationally representative data on the prevalence and comorbidity of DSM-IV alcohol and drug use disorders and independent mood and anxiety disorders (including only those that are not substance induced and that are not due to a general medical condition). Design Face-to-face survey. Setting The United States. Participants Household and group quarters' residents. Main Outcome Measures Prevalence and associations of substance use disorders and independent mood and anxiety disorders. Results The prevalences of 12-month DSM-IV independent mood and anxiety disorders in the US population were 9.21% (95% confidence interval [CI], 8.78%-9.64%) and 11.08% (95% CI, 10.43%-11.73%), respectively. The rate of substance use disorders was 9.35% (95% CI, 8.86%-9.84%). Only a few individuals with mood or anxiety disorders were classified as having only substance-induced disorders. Associations between most substance use disorders and independent mood and anxiety disorders were positive and significant ( P Conclusions Substance use disorders and mood and anxiety disorders that develop independently of intoxication and withdrawal are among the most prevalent psychiatric disorders in the United States. Associations between most substance use disorders and independent mood and anxiety disorders were overwhelmingly positive and significant, suggesting that treatment for a comorbid mood or anxiety disorder should not be withheld from individuals with substance use disorders.
2,617 citations
••
TL;DR: Cellular adaptations in prefrontal glutamatergic innervation of the accumbens promote the compulsive character of drug seeking in addicts by decreasing the value of natural rewards, diminishing cognitive control (choice), and enhancing glutamatorgic drive in response to drug-associated stimuli.
Abstract: Objective: A primary behavioral pathology in drug addiction is the overpowering motivational strength and decreased ability to control the desire to obtain drugs. In this review the authors explore how advances in neurobiology are approaching an understanding of the cellular and circuitry underpinnings of addiction, and they describe the novel pharmacotherapeutic targets emerging from this understanding. Method: Findings from neuroimaging of addicts are integrated with cellular studies in animal models of drug seeking.
2,496 citations
Authors
Showing all 3054 results
Name | H-index | Papers | Citations |
---|---|---|---|
George F. Koob | 171 | 935 | 112521 |
Nora D. Volkow | 165 | 958 | 107463 |
Ted M. Dawson | 155 | 537 | 94434 |
Kjell Fuxe | 142 | 1479 | 89846 |
Valina L. Dawson | 136 | 451 | 76986 |
Joanna S. Fowler | 131 | 577 | 65641 |
David Vlahov | 124 | 780 | 64452 |
Michael J. Kuhar | 121 | 573 | 55398 |
Bryan L. Roth | 117 | 532 | 55690 |
Gene-Jack Wang | 115 | 397 | 50773 |
Elliot K. Fishman | 112 | 1335 | 49298 |
Lars Olson | 108 | 498 | 42512 |
Leslie G. Ungerleider | 108 | 259 | 56916 |
Frank Porreca | 102 | 610 | 36395 |
Neil E. Caporaso | 100 | 497 | 35734 |